Get started
CVS HEALTH CORPORATION CEDEAR EACH 15 REP 1 ORD (USD)CVS HEALTH CORPORATION CEDEAR EACH 15 REP 1 ORD (USD)CVS HEALTH CORPORATION CEDEAR EACH 15 REP 1 ORD (USD)

CVS HEALTH CORPORATION CEDEAR EACH 15 REP 1 ORD (USD)

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

CVSD trade ideas

CVS to Long, from 53 to 58Existing Condition: 1. 05/17/2019 Weekly demand zone confirmed 2. in 15 min, down trendline break by breakaway Gap (G1) 3. Re-test the Gap, Gap filled. Entry below 53.2 Stop: 51.8 Target1: 58; Risk:reward=1:3 Target2: 61; Risk:reward=1:5 If G2 (breakwayGap up) breaks the 2nd down trend line. That is a confirmation of trend reversal. That is another entry point. This is a trading school homework. I need 6 months to practice trading plan. If you like it, thank you for your support. Please use SIM/Demo account to try it, until my trading plans get high winning rate. In my real trade, I use options. I bought Jun 57.5 Call, limit 3.5 (it is 3.2 now). If stop: lose about 1.00. Sum of my ideas: 3 active 4 winner, 1 loser, 8 cancelled, 0 pending for condition, 4 analysis only.
NYSE:CVSLong
by PlanTradePlanMM
$CVS can fall in the next daysContextual immersion trading strategy idea. CVS Health Corporation has a strong downside trend. Despite the spread of COVID-19 and the potential to demands rising, the company has some problems with revenue and costs. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $52,31; stop-loss — $54,73. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NYSE:CVSShort
by KozakHlib
CVS - weekly chart cycle analysisToday I am going to review the chart for CVS health Corporation on a weekly timeframe. CVS seems to be following in 18 to 19 week cycle and we saw the latest cycle low being formed with the candle reflecting 27 Jan 2020. On 12th Feb 2020, CVS reported earnings that broadly beat the street’s estimates. CVS reported adjusted EPS of $1.73, which beat estimates of $1.68. The company reported revenue of $66.9B, which also beat estimates of $63.97B. The company forecasted annual EPS from $7.04 – $7.17 in 2020, which was in-line with analyst expectations of $7.15 Lets look at what the charts are suggesting. CVS has started the upward move as suggested with the beginning of the cycle over the last couple of weeks after bottoming out around $ 67.81 levels. CVS is in a very bullish intermediate-term cycle pattern with negative momentum. Given these conditions, we would expect short-term sell-offs to be limited to the intermediate Fibonacci support zone beginning at 70.58. There is a likelihood the stock tests 79 by May 2020 Price is inching upwards towards 75-76 levels, which is the first zone of resistance. This level is important resisitance as this reflects previous cycle high (failed upward move) witnessed during Nov 2019 to Mid Jan 2020. Also, this level shows confluence with Fib levels.... 0.786 levels and hence may act as short term resistance . Once this is cleared, next resistance at 81 to 82.5 levels. As indicated in the chart, this is also cycle high and the previous peak levels , where prices failed to hold on and got into a major declining phase. These levels were last witnessed in Nov and Dec 2018. Price should find support around 69 to 71 levels in the short term. For the bears to regain control and for us to revisit our belief, we will require a daily price close below 66.73 If you like what you see, then please share your comments in the box below and share a thumbs up!
NYSE:CVSLong
by LoveForCharts
1
CVS is back!After a press release indicating that CVS Health plans to open 600 new Health Hub stores this year, CVS stock has once again been climbing. I suspect the breakout will continue once CVS pushes through some resistance. I'm looking for maybe $78 per share from this run. CVS's forward P/E of about 10.5 is very attractive for a stock with large growth prospects in the next 2 years. We've got a healthcare cost bubble in the USA, and CVS may be on the leading edge of popping that bubble with its low-cost clinic model. It also boasts a roughly 2.5% dividend.
NYSE:CVSLong
by ChristopherCarrollSmith
1
CVS - DAILY CHART Hi, today we are going to talk about CVS Health Corp and its current landscape. CVS is poised to receive increasing attention from the market as relevant events are taking place. The healthcare company can be benefited from the implied move that Congress will repeal three key Obamacare aspects related to the health industry taxes as part of fiscal 2020 spending bills. News that can boost CVS next year. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
NYSE:CVS
by Igor-Silva
$CVS Health Bullish but still in downtrend.Bullish run in 2019, but is becoming overbought, despite the gains in 2019 the stock is still in a long term downtrend and we would remains on the sidelines until that channel is broken. There is plenty of upside so need to jump in at the end of the current run, better entries will present themselves. 19.87 P/E ratio, very reasonable. 2.82% yield. Company profile CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
NYSE:CVS
by Bullishcharts
CVS moment of truth is comingCVS has been headed toward the top of its parallel channel. It's currently overbought, so its first test of the channel top may get rejected. However, expect a breakout soon after. CVS is my favorite investment thesis in the entire market right now. The company is opening 1500 HealthHub stores by the end of 2021 and is also completing a merger with Aetna. Its earnings are expected to grow, and the stock is absurdly undervalued. Fair value based on forward P/E for 2021 is something like $95 per share. Even based on this year's P/E, it should be at least $79. (I base these numbers on the Zack's "Price and Consensus" chart, which is one of my favorite tools for fundamental analysis. We'll do an educational episode on this on the "Wall Street Petting Zoo" Youtube channel next week.)
NYSE:CVSLong
by ChristopherCarrollSmith